Y-MABS THERAPEUTICS INC. - COMMON STOCK
6.0000
04-February-25 15:45:00
15 minutes delayed
Stocks
+0.2000
+3.45%
Today's range
5.7500 - 6.0700
ISIN
N/A
Source
NASDAQ
-
Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines Agency
27 Apr 2021 15:01:00 By Nasdaq GlobeNewswire
-
Y-mAbs Provides Regulatory Update on Omburtamab
20 Apr 2021 08:00:01 By Nasdaq GlobeNewswire
-
Y-mAbs Announces GPA33-SADA Data Presented at AACR
12 Apr 2021 08:00:00 By Nasdaq GlobeNewswire
-
Y-mAbs Announces 2020 Financial Results and Recent Corporate Developments
25 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
-
22 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
-
Y-mAbs to Announce 2020 Financial and Operating Results on February 25, 2021
19 Feb 2021 08:00:00 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Pricing of Public Offering of Common Stock
17 Feb 2021 18:14:43 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Proposed Public Offering of Common Stock
16 Feb 2021 15:01:00 By Nasdaq GlobeNewswire
-
Y-mAbs Therapeutics to Present At 39th Annual J.P. Morgan Healthcare Conference
06 Jan 2021 08:00:00 By Nasdaq GlobeNewswire